Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Journal of Midwifery

The Safety of Radioiodine Therapy for Women of Reproductive Age Aisyah Elliyanti
Journal of Midwifery Vol 4, No 1 (2019): Published on June 2019
Publisher : Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (377.188 KB) | DOI: 10.25077/jom.4.1.1-6.2019

Abstract

Radioiodine (131I) is  an essential adjuvant treatment after thyroidectomy in patients with differentiated thyroid carcinoma as well as Graves’ disease (hyperthyroidism). Generally 131I is safe, It has some side effects. Infertility is one an important issues for patients who will consider to receive the therapy, especially for woman in reproductive age.  This is reviewed in this paper. Studies reported, in hyperthyroidism and thyroid cancer patients who received  131I therapy, demonstrated no significant radiation effect, some of patients may have experienced short-term reproductive organs disfunction and changes generally resolve. There is no effect of 131I to subsequent pregnancy documented.